Ventilator Patients In Australia: Counting The Numbers

how many people on ventilators in australia

During the COVID-19 pandemic, the number of people on ventilators in Australia became a critical issue. In March 2020, there were concerns about a global shortage of ventilators and personal protective equipment, with Western Australia facing a shortage of ventilators and doctors fearing they would need to prioritize treating younger patients with higher chances of survival. Australia had about 2,000 ventilators in ICU units at the time, and the government aimed to increase this number to 4,000. By April 2020, Australia had more than sufficient ventilator capacity, with only 35 of the most critically ill COVID-19 patients requiring ventilators. The country continued to build its ventilator capacity, with a goal of reaching 10,000 ventilators for intensive care.

Characteristics Values
Number of ventilators in Western Australia 253 adult ventilators, 14 for babies
Number of ventilators in Australia in March 2020 2,000
Number of ventilators in Australia in March 2020 attached to ICU beds 2,300
Number of COVID-19 patients in Australia requiring ventilators in April 2020 35
Number of ventilators Australia is building towards 10,000
Number of ventilators Australia is looking to source 5,000

shunculture

Australia's ventilator capacity

As the pandemic progressed, Australia took several measures to increase its ventilator capacity. Authorities worked to source an additional 5,000 ventilators, with the aim of reaching a total of about 10,000 ventilators for intensive care. This included ordering 1,000 invasive ventilators from a Melbourne firm, ResMed, and procuring non-invasive ventilators from four companies: ResMed, GE, Philips, and Medtronic. The government also collaborated with local manufacturers to pivot their operations towards ventilator production.

The Queensland health department acquired 110 additional ventilators, while the NSW Health department planned for a potential increase in patients requiring respiratory care. Australia's national COVID-19 pandemic plan also outlined strategies such as higher patient-to-nurse ratios in ICUs.

By April 2020, Deputy Chief Medical Officer Nick Coatsworth stated that Australia had more than sufficient ventilator capacity, with a national target of 7,500 ventilators, almost triple the pre-pandemic number. At that time, Australia had 4,400 ventilators, with only 35 COVID-19 patients requiring their use.

To address the potential shortage of qualified staff to operate ventilators, over 12,000 nurses enrolled in an online training program to upskill in providing intensive care.

shunculture

Ventilator shortages in Western Australia

In March 2020, Western Australia faced a shortage of ventilators as the coronavirus pandemic saw cases soar to 237 nationwide. The state needed to double its number of ventilators in case COVID-19 patients developed pneumonia, which could have serious effects on the elderly. The ventilator shortage threatened to present WA doctors with an ethical dilemma: whether to prioritise the treatment of young and otherwise healthy COVID-19 patients over elderly patients.

At the time, there were 253 adult ventilators in WA's public hospitals, as well as 14 for babies, with an additional 51 en route after the McGowan Government spent $2.2 million on medical equipment to combat the coronavirus crisis. However, the WA Government acknowledged that more ventilators would be needed. Health Minister Roger Cook stated, "I understand people are looking for certainty out of the COVID-19 outbreak. The one thing I can not provide you with is certainty... Our procurement team is literally working around the clock as they utilise the global time zones to try to access all the equipment we need."

The ventilator shortage in Western Australia was part of a broader issue affecting other countries, such as Italy, and raised questions about the ethical approaches to allocating medical care during the pandemic. Some argued for equality of access, where everyone should have an equal chance of treatment regardless of age, race, disability, or any other factor. Others suggested considering the expected outcome of treatment, prioritizing those with a higher probability of survival to save more lives.

To address the ventilator shortage in Australia, authorities worked to source an additional 5,000 ventilators, aiming to boost the country's capacity to around 10,000 ventilators for intensive care. This included ordering 1,000 invasive ventilators from Melbourne firm ResMed and producing "non-invasive" ventilators with the help of four firms: ResMed, GE, Philips, and Medtronic.

shunculture

Global ventilator shortages

Ventilators are life-support systems that help patients breathe. They are critical in the treatment of severe COVID-19 cases, where patients experience difficulty in getting enough oxygen into their lungs. During the COVID-19 pandemic, the demand for ventilators surged worldwide, leading to critical shortages in many countries, including the United States.

In Australia, the government initially aimed to double the number of ventilators available, targeting 4,000 machines. However, as the pandemic progressed, the focus shifted to sourcing and producing additional ventilators to meet the growing demand. Health authorities worked to secure 5,000 more invasive and non-invasive ventilators, with the goal of reaching a capacity of 10,000 ventilators for intensive care. This was achieved through a combination of sourcing new Australian-made ventilators, placing orders with local firms, and repurposing ventilators from other areas of hospitals.

The global ventilator shortage during the pandemic was a complex issue. While increasing ventilator production was crucial, it was not a simple task due to the limited number of companies with the expertise to manufacture these specialised devices. The situation prompted a worldwide search for solutions, with efforts focused on acquiring ventilators from various sources and maximising production capacity. The United States government, for example, invoked the Defense Production Act to direct private companies to produce ventilators and increase raw material availability.

In addition to the shortage of ventilators, there was also a critical need for personal protective equipment (PPE) for frontline healthcare workers. This included items such as respirators, gloves, face shields, gowns, and hand sanitiser. Inadequate access to PPE resulted in high rates of infection and death among healthcare workers, particularly in countries like Italy.

To address the ventilator shortage, innovative solutions were explored, such as the use of "'splitters'" to enable shared ventilation between multiple patients. However, these solutions had limitations and were not always effective in addressing the shortage. The pandemic highlighted the importance of accurate predictions and a multipronged strategy to ensure sufficient ventilator capacity and protect the health and safety of both patients and healthcare workers.

shunculture

Ventilator manufacturing in Australia

Ventilators are crucial to the survival of those worst hit by the coronavirus. In response to the COVID-19 outbreak, a Commonwealth Government task force in Australia has been working to identify domestic manufacturing capabilities for ventilators. Led by Australia's Chief Scientist, Dr Alan Finkel, the task force has compiled a document detailing the minimum technical requirements for invasive ventilators suitable for use in hospitals. This document serves as a guide for domestic manufacturers to support the country's efforts in managing the pandemic.

In March 2020, Australia had approximately 2,000 ventilators in ICU units, and the government aimed to double that number to 4,000. However, doctors were concerned that even with the increased number of ventilators, there might not be enough critical care staff to operate them. As a result, health authorities worked to source an additional 5,000 ventilators, aiming for a capacity of about 10,000 ventilators for intensive care.

To achieve this, Australia turned to both existing and new manufacturers. ResMed, a sleep apnea business, was one of the existing manufacturers that aimed to double or triple its ventilator output. Additionally, four firms, ResMed, GE, Philips, and Medtronic, stepped in to produce non-invasive ventilators. Furthermore, vehicle engineer Holden Special Vehicles, new to the field, also answered the call to boost ventilator manufacturing.

The Therapeutic Goods Administration (TGA) in Australia has been actively monitoring the safety and performance of ventilators included in the Australian Register of Therapeutic Goods (ARTG). They have requested that sponsors provide evidence that the ventilators meet the ventilation delivery and monitoring specifications. The TGA is also encouraging consumers and health professionals to report any problems with medical devices, including ventilators, to contribute to their monitoring efforts.

shunculture

Ventilator usage in ICUs

Ventilators are a crucial component of intensive care units (ICUs), providing life-saving support for patients with severe respiratory issues. In the context of the COVID-19 pandemic, ventilators have been in high demand worldwide, and Australia has also faced the challenge of ensuring sufficient ventilator capacity.

In March 2020, Australia had approximately 2,000 ventilators in its ICU units, with the government aiming to double that number to 4,000. However, with the COVID-19 pandemic, it became evident that even more ventilators might be needed. Health authorities worked to source an additional 5,000 ventilators, aiming for a total capacity of 10,000 ventilators in intensive care. This included both invasive and non-invasive ventilators, with some sourced from firms like ResMed, GE, Philips, and Medtronic.

The situation varied across the country, with Western Australia facing particular challenges. In March 2020, there were only 253 adult ventilators in Western Australia's hospitals, leading to concerns about potential shortages and ethical dilemmas in treatment prioritisation. However, the WA Government worked tirelessly to procure additional equipment, and by April 2020, Australia had a "more than sufficient" ventilator capacity, according to the Deputy Chief Medical Officer.

The effective utilisation of ventilators in ICUs depends on several factors. Firstly, there must be enough trained staff to operate the machines. This includes anaesthesiologists, intensive care doctors, and specifically trained intensive care nurses. Secondly, the availability of other equipment and resources is crucial. Setting up intensive care in coronary care spaces, post-operative areas, and decommissioned areas may help increase ventilator capacity.

In conclusion, ventilator usage in ICUs is a critical aspect of healthcare, especially during a pandemic. Australia faced the challenge of ensuring sufficient ventilator capacity by sourcing additional units and addressing staffing and resource needs. The efforts made helped the country achieve a "more than sufficient" ventilator capacity to care for COVID-19 patients.

Frequently asked questions

As of April 2020, 35 of the most critically ill COVID-19 patients in Australia's intensive care units were on ventilators.

Australia has about 2,000 ventilators in its intensive care units. The government is working to increase this number to 4,000 or more.

COVID-19 patients who require ventilation typically spend about two weeks on the machine.

Australia has been working to increase its ventilator capacity to meet the demands of the COVID-19 pandemic. While there were initial concerns about potential shortages, the Deputy Chief Medical Officer has stated that Australia has "more than sufficient" ventilator capacity.

Written by

Explore related products

Reviewed by
Share this post
Print
Did this article help you?

Leave a comment